Home:
Educational
Supplement: Section 2
SELECT PUBLICATIONS
Ames F et al.
Tumor location and nodal drainage patterns on lymphoscintigraphy
are predictors of axillary sentinel lymph node status. Proc
ASCO 2001; Abstract
155.
Bevilacqua JLB
et al. Detection of axillary node positivity is increased with
sentinel lymph node biopsy in early stage breast carcinoma.
Breast Cancer Res Treat 2000; Abstract
104.
Bevilacqua JLB
et al. The first 2,000 cases axillary node metastases
in the sentinel lymph node era. Breast Cancer Res Treat 2000;
Abstract
105.
Breslin TM et
al. Sentinel lymph node biopsy is accurate after neoadjuvant
chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-6.
Abstract
Chetty U et
al. Management of the axilla in operable breast cancer treated
by breast conservation: A randomized clinical trial. Edinburgh Breast
Unit. Br J Surg 2000;87:163-9. Abstract
Cody HS 3rd.Clinical
aspects of sentinel node biopsy.
Breast Cancer Res. 2001;3:104-8. Abstract
Dessureault
S et al. Early results of breast cancer lymphatic mapping from
the H Lee Moffitt Cancer Center: No axillary recurrences in breast
cancer patients after a negative sentinel lymph node biopsy.
Breast Cancer Res Treat 2000;Abstract
1.
Edge SB et al.
Rapid implementation of sentinel node biopsy for breast cancer
at cancer centers. Proc ASCO 2001; Abstract
153.
Fisher B et
al. Ten-year results of a randomized clinical trial comparing
radical mastectomy and total mastectomy with or without radiation.
N Eng J Med 1985;312:674-681. Abstract
Gemignani ML,
Borgen PI. Is there a role for selective axillar y dissection
in breast cancer? World J Surg. 2001;25:809-18. Abstract
Grube BJ et
al. A decade of sentinel lymph node mapping in breast cancer:
A hypothesis-driven journey toward a new paradigm. Poster,
2001 Miami Breast Cancer Conference. Full-Text
Hansen NM et
al. Clinical significance of axillary micrometastases in breast
cancer: How small is too small? Proc ASCO 2001;Abstract
91.
Keshtgar MR,
Baum M. Axillary dissection over the years: Where to from here?
World J Surg 2001;25:761-6. Abstract
Krag D. Minimal
invasive staging for breast cancer: Clinical experience with sentinel
lymph node biopsy. Semin Oncol 2001;28:229-35. Abstract
Haigh PI et
al. Surgery for diagnosis and treatment: Sentinel lymph node
biopsy in breast cancer. Cancer Control 1999;6(3):301-306.
Full-Text
Hsueh EC et
al. Intraoperative lymphatic mapping and sentinel lymph node
dissection in breast cancer. CA Cancer J Clin 2000;50(5):279-91.
Full-Text
Lambah PA et
al. Long term results of randomised studies of axillary clearance
vs non-targeted axillary sampling. Breast Cancer Res Treat
2000;Abstract
109.
Mansel RE. The
UK Almanac Trial (MRC) - Early Results. Poster, 2001 Miami
Breast Cancer Conference. Full-Text
Mateos JJ et
al. Sentinel lymph node biopsy in breast cancer patients: Subdermal
versus peritumoural radiocolloid injection. Nucl Med Commun
2001;22:17-24. Abstract
Morrow M et
al. Learning sentinel node biopsy: Results of a prospective randomized
trial of two techniques. Surgery 1999;126(4):714-20; discussion
720-2. Abstract
Nieweg OE et
al. Is lymphatic mapping in breast cancer adequate and safe?
World J Surg 2001;25:780-8. Abstract
Noguchi M. Sentinel
lymph node biopsy as an alternative to routine axillary lymph node
dissection in breast cancer patients. J Surg Oncol 2001;76:144-56.
Abstract
O'Sullivan M
et al. Preliminary results of changes in the quality of life
in patients undergoing sentinel lymph node mapping or axillary clearance
for early breast cancer. Proc ASCO 2001;Abstract
1900.
Owen DH. The
Intradermal Sentinel Node: Update 2000. Poster, 2001 Miami
Breast Cancer Conference. Full-Text
Reynolds C et
al. Sentinel lymph node biopsy with metastasis: Can axillary
dissection be avoided in some patients with breast cancer? J
Clin Oncol 1999;17:1720-6. Abstract
Rodier JF et
al. Lymphatic mapping and sentinel node biopsy of operable breast
cancer. World J Surg 2000;24:1220-5; discussion 1225- 6.
Abstract
Sakorafas GH.
Breast cancer surgery--historical evolution, current status and
future perspectives. Acta Oncol 2001;40:5-18. Abstract
Singletary SE.
Systemic treatment after sentinel lymph node biopsy in breast
cancer: Who, what and why? J Am Coll Surg 2001;192:220-30.
Abstract
Tafra L et al.
Multicenter trial of sentinel node biopsy for breast cancer using
both technetium sulfur colloid and isosulfan blue dye. Ann
Surg 2001;233:51-9. Abstract
Veronesi U et
al. Sentinel lymph node biopsy and axillary dissection in breast
cancer: Results in a large series. J Natl Cancer Inst
1999;91:368-73. Abstract
Wayne JD et
al. Anaphylactic reaction to isosulfan blue dye (IBD) during
sentinel lymph node biopsy (SLNB) is more common in breast cancer
than in melanoma. Proc ASCO 2001;Abstract
150.
Weaver DL.
Sentinel lymph node biopsy in breast cancer: Creating controversy
and defining new standards. Adv Anat Pathol 2001;8:65- 73.
Abstract
Wong SL et al.
Sentinel lymph node biopsy for breast cancer: Impact of the number
of sentinel nodes removed on the false-negative rate. J
Am Coll Surg 2001;192:684-9; discussion 689-91. Abstract
Woolam GL.
What's new in breast cancer surgery? CA Cancer J Clin 2000;
50(5):276-8. Full-Text
Top
OTHER
RESOURCES
Beitsch PS.
SLNB slide presentation with photographs of the procedure.
Web link
Comprehensive
NCI patient education monograph on SLNB: Includes review of NSABP
and ACOS trials. Web
link
Top
Additional
Sections:
1 | 2
| 3 | 4
| 5 | 6
| 7 | 8
| 9 | 10
| 11 | 12
|
|